Skip to main content
Esc

Type to search

Articles / institutional-equities / Here are JPMorgan's favorite stocks heading into June

Here are JPMorgan's favorite stocks heading into June

Jun 3, 2026 · Source: cnbc.com · Topic:  institutional-equities · fintech
Nasdaq Composite Growth
8%
The percentage increase in the Nasdaq Composite index in May.
S&P 500 Growth
5%
The percentage increase in the S&P 500 index in May.
Eli Lilly Stock Rise
73%
The percentage increase in Eli Lilly's stock compared to its 52-week low.

§ 01 Executive Snapshot

  • What: JPMorgan updated its list of top stock recommendations for June.
  • Who: Key players include JPMorgan analysts, Eli Lilly, CVS Health, Viasat, and Lockheed Martin.
  • Why it matters: The update reflects the current market trends and highlights stocks poised for growth, particularly in the technology and healthcare sectors.

§ 02 Key Developments

  • The S&P 500 surged 5% in May, with the Nasdaq Composite climbing more than 8%.
  • Viasat was added to JPMorgan's top picks, experiencing over 730% growth in the past year despite a recent 16% drop after filing a shelf registration.
  • Eli Lilly is noted for its dominance in the weight loss drug market and has seen its stock rise 73% above its 52-week low, closing at an all-time high.

§ 03 Strategic Context

  • The strong performance of U.S. stocks, particularly in technology, signals a robust recovery and investor confidence in growth sectors.
  • JPMorgan's selection of stocks reflects broader trends in healthcare innovation and advancements in satellite communications technology.

§ 04 Strategic Implications

  • Immediate implications include increased interest in growth-oriented stocks, particularly in tech and healthcare, which could drive further investment and market volatility.
  • Long-term implications may involve shifts in market leadership as companies like Eli Lilly and Viasat capitalize on emerging trends and technologies.

§ 05 Risks & Constraints

  • Potential risks include market fluctuations that could impact the performance of recommended stocks, particularly in volatile sectors like tech.
  • Regulatory scrutiny over stock offerings, as seen with Viasat's recent SEC filing, may pose challenges for companies looking to raise capital.

§ 06 Watchlist / Forward Signals

  • Upcoming earnings reports and market reactions to new product launches will be critical in assessing the performance of the recommended stocks.
  • Any regulatory actions or changes in market conditions affecting the healthcare and satellite communication sectors will be key indicators of future success or challenges.
§ 07

Frequently Asked Questions

What stocks did JPMorgan recommend for June?

JPMorgan's top stock recommendations for June include Eli Lilly, CVS Health, Viasat, and Lockheed Martin.

Why is Viasat significant in this update?

Viasat was added to JPMorgan's top picks after experiencing over 730% growth in the past year, despite a recent 16% drop.

How has Eli Lilly performed recently?

Eli Lilly has seen its stock rise 73% above its 52-week low and closed at an all-time high, largely due to its dominance in the weight loss drug market.

What are the potential risks mentioned for these stocks?

Potential risks include market fluctuations that could impact stock performance and regulatory scrutiny over stock offerings.

§ 08

Related Articles